Robert Reynolds in Clinton, Oklahoma

Home Oklahoma Clinton

Robert Reynolds has Medical Oncology as his primary medical specialty. Their primary office is: 100 N 30th St in Clinton, Oklahoma.

They're a part of the: Robert Reynolds, M.d., P.c. medical group which has around 6 members. You can call their office at 405-752-0871 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Oklahoma College Of Medicine and graduated in 1996 (around 28 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Robert E Reynolds Office Phone and Directions

Robert Reynolds
Robert Reynolds, M.d., P.c.
100 N 30th St
Clinton, Oklahoma 73601
405-752-0871

Patient Ratings
Please rate your experience with Robert Reynolds below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 405-752-0871

Enter a starting address:

Healthcare Info for Robert Reynolds

Additional Medical Specialties Include:
HEMATOLOGY/ONCOLOGY

Medical School: University Of Oklahoma College Of Medicine
Graduation Year: 1996
The Primary Medical Specialty for Robert Reynolds is listed as: Medical Oncology
Approximate Years of Experience: 28
PAC (PECOS ID)#: 6709928054
NPI #: 1649275827
NPI Created On: 06/15/2005
NPI Last Updated Listed as: 07/08/2007
Primary Taxonomy Code: 207RH0003X
License Number:
20272
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Complete blood cell count (red cells, white blood cell, platelets), automated test
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
Infusion of different chemotherapy drug or substance into a vein
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
Infusion of different chemotherapy drug or substance into a vein up to 1 hour
Irrigation of implanted venous access drug delivery device
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Injection, leucovorin calcium, per 50 mg
Injection, denosumab, 1 mg
Injection, dexamethasone sodium phosphate, 1 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788519487

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788519489

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781014201

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 828516073

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Genetic Disease

Name of Drug #1: GIVLAARI

Open Associated Drug #1: 71336-1001-1

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 828516153

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Genetic Disease

Name of Drug #1: GIVLAARI

Open Associated Drug #1: 71336-1001-1

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818728517

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818729261

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818735671

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802224257

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802924821

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01

Medical Oncology Professionals in Clinton

1.
Sanjaykumar Hapani

100 N 30th St
Clinton, OK
Robert Reynolds, M.d., P.c.

Providers in Robert Reynolds, M.d., P.c.

1.Angela Bogner

100 N 30th St
Clinton Ok 73601-3117
Robert Reynolds, M.d., P.c.
Nurse Practitioner

2.Sanjaykumar Hapani

100 N 30th St
Clinton Ok 73601-3117
Robert Reynolds, M.d., P.c.
Medical Oncology

3.Hassan Kaleem

100 N 30th St
Clinton Ok 73601-3117
Robert Reynolds, M.d., P.c.
Radiation Oncology

4.Robert Reynolds

100 N 30th St
Clinton Ok 73601-3117
Robert Reynolds, M.d., P.c.
Medical Oncology

5.Jehanzeb Riaz

100 N 30th St
Clinton Ok 73601-3117
Robert Reynolds, M.d., P.c.
Hematology/oncology

6.Ravikumar Vasireddy

100 N 30th St
Clinton Ok 73601-3117
Robert Reynolds, M.d., P.c.
Hematology/oncology

View all 6 members of Robert Reynolds, M.d., P.c. medical group